These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3322320)

  • 21. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
    Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypercholesterolaemia: A global call to arms.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK
    Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930
    [No Abstract]   [Full Text] [Related]  

  • 24. Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemia.
    Sposito AC; Gonbert S; Bruckert E; Atassi M; Beucler I; Amsellem S; Khallouf O; Benlian P; Turpin G
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2078-82. PubMed ID: 14512370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of gene technology in the diagnosis of familial hypercholesterolemia].
    Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial hypercholesterolemia. Study of low-density lipoprotein receptors. Treatment with plasmapheresis].
    Bellini C; Bonioli E; Ruffa G; Franchini E; Rivabella L; Cinollo G; Catapano A; Fumagalli R; Corsini A; Gemme G
    Minerva Pediatr; 1986 Oct; 38(20):893-902. PubMed ID: 3796552
    [No Abstract]   [Full Text] [Related]  

  • 27. Origin and migration of an Afrikaner founder mutation FHAfrikaner-2 (V408M) causing familial hypercholesterolemia.
    Defesche JC; Van Diermen DE; Hayden MR; Kastelein JP
    Gene Geogr; 1996 Apr; 10(1):1-10. PubMed ID: 8913716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying patients with familial hypercholesterolaemia in primary care.
    Humphries SE; Hadfield G
    Heart; 2008 Jun; 94(6):695-6. PubMed ID: 18480347
    [No Abstract]   [Full Text] [Related]  

  • 29. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial hypercholesterolaemia and coronary disease in South Africa.
    Pedoe HT
    Br Med J; 1980 Sep; 281(6244):872. PubMed ID: 7427490
    [No Abstract]   [Full Text] [Related]  

  • 31. [Remnant receptor].
    Yamada N
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():317-9. PubMed ID: 11351597
    [No Abstract]   [Full Text] [Related]  

  • 32. Familial hypercholesterolaemia in South Africa: A reminder.
    Marais AD; Blom DJ; Raal FJ; The Lipid And Atherosclerosis Society Of Southern Africa OBOTLA
    S Afr Med J; 2021 Aug; 111(8):700-701. PubMed ID: 35227347
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial hypercholesterolaemia and church affiliation.
    Torrington M; Botha JL
    Lancet; 1981 Nov; 2(8255):1120. PubMed ID: 6118572
    [No Abstract]   [Full Text] [Related]  

  • 34. [he Nobel Prize for Medicine 1985: studies by M.S. Brown and J.L. Goldstein on (the lack of) control of cholesterol metabolism].
    Hülsmann WC
    Ned Tijdschr Geneeskd; 1986 Feb; 130(5):195-7. PubMed ID: 3513032
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of familial hypercholesterolemia.
    de Villiers LS; Serfontein WJ
    S Afr Med J; 1986 Sep; 70(7):435-6. PubMed ID: 3764618
    [No Abstract]   [Full Text] [Related]  

  • 36. Protein domains of the low density lipoprotein receptor.
    Russell DW
    Acta Med Scand Suppl; 1987; 715():39-44. PubMed ID: 3473914
    [No Abstract]   [Full Text] [Related]  

  • 37. Discovering familial hypercholesterolaemia.
    Blom DJ; Raal FJ; Marais AD
    S Afr Med J; 2008 Apr; 98(4):232. PubMed ID: 18642461
    [No Abstract]   [Full Text] [Related]  

  • 38. The receptor model for transport of cholesterol in plasma.
    Brown MS; Goldstein JL
    Ann N Y Acad Sci; 1985; 454():178-82. PubMed ID: 3907461
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigations on a child with familial hypercholesterolaemia.
    Zetterström R
    Acta Paediatr; 2011 Feb; 100(2):311-3. PubMed ID: 20860704
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of ligand-receptor interactions in disease.
    Vermeer BJ; Leuven JA
    J Dermatol Sci; 1990 Mar; 1(2):59-64. PubMed ID: 2100546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.